The Croatian Laboratory Problem An important limitation affects the credibility of the entire BPC-157 literature: the vast majority of research - both preclinical and the few clinical studies - originates from Croatian research institutions, primarily centered around the University of Zagreb
No therapeutic, diagnostic, or dosing claims are made
But I mean, again, this is where we are, is there so much, you know, disinformation or bad information, as you said, that it's becoming harder and harder for smart people to actually find the correct information
Medycyna rodowiskowa
We guide you through a proven, step-by-step approach that ensures results are effective, measurable, and sustainable
Paying $180 at Peptide Sciences versus $40 at Limitless Biotech for what might be the same batch is a real question researchers need to sit with